These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

417 related articles for article (PubMed ID: 32927853)

  • 21. Resolution of Inflammation after Skeletal Muscle Ischemia-Reperfusion Injury: A Focus on the Lipid Mediators Lipoxins, Resolvins, Protectins and Maresins.
    Barnig C; Lutzweiler G; Giannini M; Lejay A; Charles AL; Meyer A; Geny B
    Antioxidants (Basel); 2022 Jun; 11(6):. PubMed ID: 35740110
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Natural resolution of inflammation.
    Freire MO; Van Dyke TE
    Periodontol 2000; 2013 Oct; 63(1):149-64. PubMed ID: 23931059
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Formation of lipoxins and resolvins in human leukocytes.
    Kahnt AS; Schebb NH; Steinhilber D
    Prostaglandins Other Lipid Mediat; 2023 Jun; 166():106726. PubMed ID: 36878381
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Protectins and maresins: New pro-resolving families of mediators in acute inflammation and resolution bioactive metabolome.
    Serhan CN; Dalli J; Colas RA; Winkler JW; Chiang N
    Biochim Biophys Acta; 2015 Apr; 1851(4):397-413. PubMed ID: 25139562
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pro-resolving lipid mediator Resolvin D1 serves as a marker of lung disease in cystic fibrosis.
    Eickmeier O; Fussbroich D; Mueller K; Serve F; Smaczny C; Zielen S; Schubert R
    PLoS One; 2017; 12(2):e0171249. PubMed ID: 28158236
    [TBL] [Abstract][Full Text] [Related]  

  • 26. New pro-resolving n-3 mediators bridge resolution of infectious inflammation to tissue regeneration.
    Serhan CN; Chiang N; Dalli J
    Mol Aspects Med; 2018 Dec; 64():1-17. PubMed ID: 28802833
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Activation of autophagy in macrophages by pro-resolving lipid mediators.
    Prieto P; Rosales-Mendoza CE; Terrón V; Toledano V; Cuadrado A; López-Collazo E; Bannenberg G; Martín-Sanz P; Fernández-Velasco M; Boscá L
    Autophagy; 2015; 11(10):1729-44. PubMed ID: 26506892
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lipid mediators in the resolution of inflammation.
    Serhan CN; Chiang N; Dalli J; Levy BD
    Cold Spring Harb Perspect Biol; 2014 Oct; 7(2):a016311. PubMed ID: 25359497
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pro-Resolving Lipid Mediators in the Pathophysiology of Asthma.
    Kytikova O; Novgorodtseva T; Denisenko Y; Antonyuk M; Gvozdenko T
    Medicina (Kaunas); 2019 Jun; 55(6):. PubMed ID: 31216723
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Protectins: Their biosynthesis, metabolism and structure-functions.
    Vidar Hansen T; Serhan CN
    Biochem Pharmacol; 2022 Dec; 206():115330. PubMed ID: 36341938
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacological effects of specialized pro-resolving mediators in sepsis-induced organ dysfunction: a narrative review.
    Sun S; Yang D; Lv J; Xia H; Mao Z; Chen X; Gao Y
    Front Immunol; 2024; 15():1444740. PubMed ID: 39372413
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Specialized pro-resolving mediators in cardiovascular diseases.
    Fredman G; Spite M
    Mol Aspects Med; 2017 Dec; 58():65-71. PubMed ID: 28257820
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inflammation resolution: a dual-pronged approach to averting cytokine storms in COVID-19?
    Panigrahy D; Gilligan MM; Huang S; Gartung A; Cortés-Puch I; Sime PJ; Phipps RP; Serhan CN; Hammock BD
    Cancer Metastasis Rev; 2020 Jun; 39(2):337-340. PubMed ID: 32385712
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pro-resolving lipid mediators: Agents of anti-ageing?
    Doyle R; Sadlier DM; Godson C
    Semin Immunol; 2018 Dec; 40():36-48. PubMed ID: 30293857
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pro-resolution therapeutics for cardiovascular diseases.
    Heinz J; Marinello M; Fredman G
    Prostaglandins Other Lipid Mediat; 2017 Sep; 132():12-16. PubMed ID: 28450270
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The resolution code of acute inflammation: Novel pro-resolving lipid mediators in resolution.
    Serhan CN; Chiang N; Dalli J
    Semin Immunol; 2015 May; 27(3):200-15. PubMed ID: 25857211
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pro-Resolving Lipid Mediators (SPMs) and Their Actions in Regulating miRNA in Novel Resolution Circuits in Inflammation.
    Recchiuti A; Serhan CN
    Front Immunol; 2012; 3():298. PubMed ID: 23093949
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The need for precision nutrition, genetic variation and resolution in Covid-19 patients.
    Simopoulos AP; Serhan CN; Bazinet RP
    Mol Aspects Med; 2021 Feb; 77():100943. PubMed ID: 33551236
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Resolution medicine in cancer, infection, pain and inflammation: are we on track to address the next Pandemic?
    Serhan CN; Sulciner ML
    Cancer Metastasis Rev; 2023 Mar; 42(1):13-17. PubMed ID: 36781545
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Specialized pro-resolving lipid mediators in endodontics: a narrative review.
    Aubeux D; Peters OA; Hosseinpour S; Tessier S; Geoffroy V; Pérez F; Gaudin A
    BMC Oral Health; 2021 May; 21(1):276. PubMed ID: 34030680
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.